ACSL4 expression is increased in castration-resistant prostate cancer (CRPC) compared to that in hormone-naive prostate cancer [64] and is involved in the development of tumor aggressiveness in prostate cancer through the regulation of various signal transduction pathways [65]. This evidence concerns the gene ACSL4 and prostate cancer.